Astera Labs, Inc. $ALAB Shares Bought by HighTower Advisors LLC

HighTower Advisors LLC boosted its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 47.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,151 shares of the company's stock after buying an additional 2,956 shares during the period. HighTower Advisors LLC's holdings in Astera Labs were worth $546,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ALAB. Driehaus Capital Management LLC boosted its stake in Astera Labs by 16,640.4% during the fourth quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock worth $175,408,000 after buying an additional 1,316,419 shares during the last quarter. Polar Capital Holdings Plc acquired a new position in Astera Labs during the fourth quarter worth $126,812,000. Bank of Nova Scotia boosted its stake in Astera Labs by 3,742.2% during the first quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock worth $57,546,000 after buying an additional 939,300 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in Astera Labs by 4,172.8% during the fourth quarter. BNP Paribas Financial Markets now owns 816,619 shares of the company's stock worth $108,161,000 after buying an additional 797,507 shares during the last quarter. Finally, Pacer Advisors Inc. acquired a new position in Astera Labs during the first quarter worth $29,935,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Trading Down 3.7%

ALAB opened at $182.20 on Friday. The stock's 50-day moving average price is $132.43 and its 200 day moving average price is $95.65. Astera Labs, Inc. has a 12-month low of $36.85 and a 12-month high of $199.47. The firm has a market cap of $30.29 billion, a price-to-earnings ratio of 325.36, a PEG ratio of 4.80 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the prior year, the company earned $0.13 EPS. Astera Labs's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares of the company's stock, valued at approximately $88,945,534.48. This represents a 16.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer directly owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,728,116 shares of company stock valued at $239,272,181. Corporate insiders own 12.50% of the company's stock.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of recent research reports. Barclays reissued an "overweight" rating and set a $155.00 price objective (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Evercore ISI upped their price target on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. CICC Research began coverage on Astera Labs in a research note on Friday. They issued an "outperform" rating and a $190.00 price target on the stock. Roth Capital set a $100.00 price target on Astera Labs and gave the company a "buy" rating in a research note on Wednesday, May 7th. Finally, Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a research note on Monday, August 4th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $135.75.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.